| European Federation of Internal Medicine

Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

Submitted by Anonymous (not verified) on 27 June 2025 - 10:45

Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

Read more about Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Submitted by Anonymous (not verified) on 27 June 2025 - 10:44

Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Read more about Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Call for comments on the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Submitted by Anonymous (not verified) on 27 June 2025 - 10:42

Call for comments on the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Read more about Call for comments on the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Mechanical ventilator - Notified body 2696 - 10/01/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Submitted by Anonymous (not verified) on 27 June 2025 - 9:50

Mechanical ventilator - Notified body 2696 - 10/01/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Read more about Mechanical ventilator - Notified body 2696 - 10/01/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

Submitted by Anonymous (not verified) on 27 June 2025 - 9:49

Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

Read more about Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2025, 10:00 (CEST) to 21 May 2025, 11:30 (CEST)

Submitted by Anonymous (not verified) on 27 June 2025 - 8:30

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2025, 10:00 (CEST) to 21 May 2025, 11:30 (CEST)